Abstract:INTRODUCCIÓNLas enfermedades mielodisplásicas/mieloproliferativas (SMD/SMP) constituyen neoplasias clonales hematopoyéticas que reúnen características clínicas, de laboratorio y morfológi-cas que apoyan un diagnóstico tanto de síndrome mielodisplási-co como de síndrome mieloproliferativo. Dentro de este grupo de hemopatías malignas, la clasificación OMS de los tumores hematopoyéticos y de los tejidos linfoides reconoce tres enfermedades con criterios definidos (leucemia mielomonocítica crónica, leucemia mieloi… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.